Press release
High-Level Usage Of AI In Healthcare To Drive The Ineffective Esophageal Motility Treatment Market At A CAGR Of 6%
Ineffective esophageal motility treatment leads to a reduction in muscle damage and improved outcomes, improving quality of life and resulting in long-term benefits. Device-based treatment and IEMT drugs have already had a substantial impact on how symptoms of GERD and achalasia are treated.
How About Looking Through The Sample Of Ineffective Esophageal Motility Treatment Market Report? https://www.persistencemarketresearch.com/samples/31550
The first and the most important factor driving the growth of the ineffective esophageal motility treatment market is the increasing prevalence of gastroesophageal reflux disease. Other factors, such as intake of asthma medications and increasing geriatric population, are also responsible for driving the ineffective esophageal motility treatment market.
According to the latest report published by PMR, the global ineffective esophageal motility treatment market is projected to expand at a decent CAGR of around 6% during the forecast period (2020-2030).
Companies covered in Ineffective Esophageal Motility Treatment Market Report
Johnson & Johnson
Mylan Pharmaceutical
MediGus Ltd.
Torax Medical
Medtronic plc.
AstraZeneca plc.
Teva Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Limited
GlaxoSmithKline plc.
Bayer AG
Pfizer Inc.
Bausch Health Companies Inc.
LABORIE
Mederi Therapeutics, Inc.
Becton, Dickinson and Company (C. R. Bard, Inc.)
EndoGastric Solutions, Inc
Olympus
Pentax
How About Step-By-Step Insights To Ineffective Esophageal Motility Treatment Market? Look Through The "Methodology" Employed! https://www.persistencemarketresearch.com/methodology/31550
Key Takeaways from Ineffective Esophageal Motility Treatment Market Study
Significant advantages of ineffective esophageal motility treatment; improving reimbursement scenario for surgical treatment devices; increasing awareness regarding gastric reflux disease; and large patient pool for GERD, dysphagia, achalasia, and burning chest pain are key factors propelling the growth of ineffective esophageal motility treatment market in developing regions.
North America is a prominent region the global ineffective esophageal motility treatment market, while East Asia is expected to offer lucrative growth opportunities, owing to the large population base and higher incidence of GERD and dysphagia.
Higher OTC antacid consumption is poised to drive the growth of the market.
Radiofrequency ablation systems with high level precision and procedural advantages over myotomy are expected to generate significant revenue in the long term.
Increasing adoption of ineffective esophageal motility treatment drugs for quick recovery as compared to device-based treatment marks higher revenue potential.
Raw material procurement issues, drug shortages, and reduced patient visits amidst the COVID-19 pandemic will adversely affect the growth of the ineffective esophageal motility treatment market in the near term.
"Procedural accuracy achieved by treatment devices and affordability of drug-based treatment are anticipated to drive the ineffective esophageal motility treatment market. Additionally, the large patient pool will bring in steady revenue opportunities," says a PMR analyst.
Want To Keep A Tab On The Latest Findings In The Ineffective Esophageal Motility Treatment Market? Purchase Our Ineffective Esophageal Motility Treatment Market Report Now! https://www.persistencemarketresearch.com/checkout/31550
New Product Launches by Key Players to Strengthen Market Presence
Key manufacturers in the ineffective esophageal motility treatment market are mainly focusing on research & development and introduction new & advanced treatment products. For example, LINX is the new and advanced version of the LINX reflux management device that is used for the transoral incision-less fundoplication process, which is one of the important procedures for the treatment of gastroesophageal reflux disease.
The innovation of new & advanced products is a factor boosting the ineffective esophageal motility treatment market. In addition, Olympus Corporation has launched advanced versions of esophagoscopes, which have improved the treatment curve of gastroesophageal reflux disease. Manufacturers are focusing on extended indication list and higher reimbursement to draw demand and increase profitability.
Alternatively, a key factor affecting the ineffective esophageal motility treatment market is the entry of generic drug manufacturers. Market leaders are constantly working on strengthening their strategies to gain market share.
What else is in the report?
Persistence Market Research offers a unique perspective and actionable insights on the ineffective esophageal motility treatment market in its latest study, presenting historical demand assessment of 2015-2019 and projections for 2020-2030, on the basis of product (drugs and devices), indication (GERD, dysphagia, achalasia, and burning chest pain), and end user (institutional sales and retail sales), across seven key regions.
Pulmonary Fibrosis Treatment Market: https://www.persistencemarketresearch.com/market-research/pulmonary-fibrosis-treatment-market.asp
Cutaneous And Systemic Leishmaniasis Market: https://www.persistencemarketresearch.com/market-research/cutaneous-and-systemic-leishmaniasis-market.asp
Contact Us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
About Us:
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release High-Level Usage Of AI In Healthcare To Drive The Ineffective Esophageal Motility Treatment Market At A CAGR Of 6% here
News-ID: 2628869 • Views: …
More Releases from Persistence Market Research
Sportswear Fabric Market to Reach US$40.5 Bn by 2032, Growing at 5.0% CAGR
The global sportswear fabric market is undergoing a significant transformation as consumer expectations shift toward performance, comfort, sustainability, and style. As active lifestyles and fitness-oriented habits become the global norm rather than a niche trend, the fabrics used to manufacture sportswear garments are gaining immense attention among brands, manufacturers, and material innovators.
➤ Download Your Free Sample & Explore Key Insights:
https://www.persistencemarketresearch.com/samples/30859
According to recent industry projections, the sportswear fabric market size…
Image Guided Dentals Surgery Market Set to Transform Modern Implant Dentistry
Image-guided dental surgery (IGDS) represents one of the most transformative advancements in modern dentistry. As dental practices worldwide shift toward precision-driven, minimally invasive techniques, IGDS has emerged as a critical tool for improving patient outcomes, enhancing surgical accuracy, and elevating the quality of dental care. By integrating advanced imaging systems, 3D visualization, virtual planning tools, and computer-navigation technologies, IGDS systems allow clinicians to perform complex procedures with a higher degree…
Textile Sizing Chemicals Market: Growing Demand for High-Performance and Sustain …
Introduction
Textile sizing chemicals play a crucial role in the textile manufacturing chain, particularly during the weaving process. Sizing is the step where yarns-especially warp yarns-are coated with a protective adhesive film to improve strength, reduce friction, minimize hairiness, and lower breakage during weaving. This process enhances weaving efficiency and yields higher-quality fabrics with improved texture, durability, and uniformity. Without sizing chemicals, modern high-speed looms would not be able to achieve…
2-Ethylhexanoic Acid Market Trends Transforming the Industrial Chemicals Landsca …
Introduction
2-Ethylhexanoic Acid (2-EHA) is a widely used organic carboxylic acid known for its clear-to-yellowish appearance, mild odor, and excellent solubility in organic solvents. With strong chemical stability, high boiling point, and the ability to react with metals and alcohols to form esters or metal salts, 2-EHA serves as a versatile intermediate in several industrial applications. The global market for 2-EHA is deeply influenced by trends in downstream industries such as…
More Releases for Ineffective
Ineffective Esophageal Motility Treatment Market Poised for Expansion, Notes Per …
The global Ineffective Esophageal Motility (IEM) Treatment Market has entered a period of sustained growth, propelled by rising gastrointestinal disorders and increasing awareness of esophageal motility diseases. Valued at US$ 4.21 billion in 2023, the market is projected to nearly double and reach US$ 7.47 billion by 2033, expanding at a steady 5.9% CAGR. IEM, often associated with conditions such as gastroesophageal reflux disease (GERD), dysphagia, and hiatal hernia, is…
Terischwartz Associates Exposes the True Cost of Ineffective Meetings in Today's …
Image: https://www.abnewswire.com/upload/2025/07/3cd3e20ec6c36670720e5834999ed2ab.jpg
Executives across the country sit in boardrooms and virtual rooms alike, facing a steady stream of meetings that move agendas sideways, not forward. At the center of this epidemic lies a rarely acknowledged truth: most meetings lack a clear purpose, structure, or outcome. Despite their ubiquity, they remain one of the greatest hidden inefficiencies in modern business.
Evan Unger [https://www.terischwartzassociates.com/our-team/evan-unger/], managing partner at a national leadership consulting firm, studies this…
Steep learning curve and ineffective customer support keep AccountEdge second to …
Brandon, MB--May 25, 2023: AccountEdge helps small businesses establish inventory, billing, managing contacts, creating and tracking sales and purchases. It's compatible with both Mac and Windows operating systems. An on-premise and accounting management solution, it gives users the freedom to create an eCommerce platform where they can sell items online using Shopify, download orders directly to the account and synchronize the inventory items for selling. The banking tool gives…
Ineffective Esophageal Motility Treatment Market 2022 Global Market Analysis and …
Ineffective esophageal motility treatment leads to a reduction in muscle damage and improved outcomes, improving quality of life and resulting in long-term benefits. Device-based treatment and IEMT drugs have already had a substantial impact on how symptoms of GERD and achalasia are treated.
The first and the most important factor driving the growth of the ineffective esophageal motility treatment market is the increasing prevalence of gastroesophageal reflux disease. Other factors, such…
The Ineffective Esophageal Motility Treatment Market to keep pace with the lates …
The Ineffective Esophageal Motility Treatment Market is expected to witness a staggering CAGR going forward. The gamut of care is being driven by the usage of sensors, digital technologies, and wearables, thereby allowing the healthcare personnel to delve deep into the patients’ live – be it pre-operative, post-operative, or the period in between. Consumer tech companies are into making caregivers visible outside of the clinical environment a reality.
Ineffective esophageal…
The Ineffective Esophageal Motility Treatment Market to Adopt Digitization
The Ineffective Esophageal Motility Treatment Market is there to witness remarkable growth in the forecast period. The existing scenario implies the consumerization of healthcare. In other words, technology is relieving the hospital staff from providing an appropriate level of the care needed, that too, in a better way. Data-driven diagnosis has seen the light of the day in wake of habits and requirements of smartphone-oriented patients. This would be the…
